Aller au contenu principal
Accès ouvert déclaré 2026 preprint

Obesity-Related Metabolites are Associated with Incident Coronary Heart Disease and Respond to Metabolic and Bariatric Surgery

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

ABSTRACT Objective Obesity is a major risk factor for coronary heart disease (CHD). This study aims to develop a metabolite signature of body mass index (BMI-MetSig) then assess its association with incident CHD and responsiveness to metabolic and bariatric surgery (MBS). Research Design and Methods In a case-control study of incident CHD nested within the Southern Community Cohort Study (SCCS) including 600 case-control pairs, we used elastic net regression with 10-fold cross-validation to derive the BMI-MetSig. Associations of BMI-MetSig with incident CHD was examined using conditional logistic regression in the nested case-control study. Further, in a cohort of 95 patients who received MBS, we evaluated this BMI-MetSig in association with estimated 30-year cardiovascular disease (CVD) risks, which was estimated by the American Heart Association’s PREVENT equations, and examined changes of its constituent metabolites after surgery using linear mixed-effects models. Results In the SCCS, the BMI-MetSig, comprising 94 metabolites, was significantly associated with incident CHD risk among all participants (OR per standard deviation [SD] increase: 1.48; 95% CI, 1.28–1.71) and across subgroups. Among MBS patients, the BMI-MetSig was significantly associated with increased estimated 30-year risks of CHD (β per SD increase: 1.29; p<0.001) and other CVDs. Levels of 17 (20.0%) and 19 (22.4%) metabolites in the BMI-MetSig significantly changed 3- and 12-month post-surgery (FDR<0.10 and log 2 FC > 0.15), including choline and acetyl-2-aminoadipate. Conclusions The BMI-MetSig is associated with higher CHD incidence and estimated 30-year CVD risks and responds to MBS. BMI-MetSig may serve as a blood-based biomarker for cardiometabolic risk stratification and monitoring.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Obesity-Related Metabolites are Associated with Incident Coronary Heart Disease and Respond to Metabolic and Bariatric Surgery
Date Crossref
09/03/2026
Éditeur
openRxiv
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Metabolomics and Mass Spectrometry StudiesCancer, Lipids, and MetabolismCardiovascular Disease and Adiposity

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.